Stock listing

Zelluna Asa

Selected listing: A415VC · LS · EUR · DE

Zelluna Asa (Lang & Schwarz: A415VC), Health Technology. Latest release Aug 20, 2026: Zelluna ASA: Second Quarter 2026 results.

A415VC:LSEURDEUpdated October 3, 2026

Ticker: Lang & Schwarz: A415VC
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

About Zelluna Asa

The company is focused on developing innovative solutions in its sector. Zelluna Asa aims to create value through its strategic initiatives and operations.

Latest news from Zelluna Asa

Zelluna ASA: Second Quarter 2026 results

August 20, 2026

Zelluna receives Independent Data Monitoring Committee recommendation to continue patient enrolment in ZIMA-101

August 17, 2026

Zelluna ASA: Issuance of shares to Inven2 through set-off of settlement amounts under option and license agreement

August 4, 2026

Zelluna ASA awarded NOK 16 million Research Council of Norway grant

June 30, 2026

Zelluna ASA activates The Royal Marsden as second clinical site for ZIMA-101, expanding clinical execution capabilities

June 29, 2026

All Zelluna Asa news →

Research Zelluna Asa

Zelluna Asa company profile

View the public company page for Zelluna Asa on 6ix.

Zelluna Asa news

Read company news and market updates connected to Zelluna Asa.

Zelluna Asa investor events

Find investor webinars, events, and replay context for Zelluna Asa.